Drug Database
CH

chlormadinone acetate + ethinyl estradiol (Balianca / Belara / CG5025)

✓ Approved

Faes · AR · Small Molecule

What is chlormadinone acetate + ethinyl estradiol?

chlormadinone acetate + ethinyl estradiol is a small molecule developed by Faes. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesBalianca, Belara, CG5025
CompanyFaes
Drug ClassSmall Molecule
Molecular TargetAR, ESR1
RouteOral (PO)
StatusApproved
Sources: ClinicalTrials.gov, Faes

Mechanism of Action

Molecular Targets

chlormadinone acetate + ethinyl estradiol acts on 2 molecular targets:

ARandrogen receptor (TFM, NR3C4)
ESR1estrogen receptor 1 (ESR, ESTRR)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

chlormadinone acetate + ethinyl estradiol is developed for 2 unique indications across 2 therapeutic areas.

Therapeutic AreaConditionPhase
Reproductive system and breast disordersPolycystic ovaries✓ Approved
Endocrine disordersPolycystic ovarian syndrome✓ Approved

Related Research Articles

Unable to load articles right now.

Ask about chlormadinone acetate + ethinyl estradiol